Effect of ezetimibe on lipoprotein-associated phospholipase A2 mass and activity. A systematic review and meta-analysis of clinical trials
PharmaNutrition · 2026-06 · 36 · 100490
DOI: 10.1016/j.phanu.2026.100490 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PharmaNutrition, 2026-06. Verfasst von Luis E. Simental-Mendía und 3 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Simental-Mendía, L. E., Barragán-Zúñiga, L. J., Arce-Quiñones, M., & Simental-Mendía, M. (2026). Effect of ezetimibe on lipoprotein-associated phospholipase A2 mass and activity. A systematic review and meta-analysis of clinical trials. PharmaNutrition, 36, 100490. https://doi.org/10.1016/j.phanu.2026.100490
Vancouver
Simental-Mendía LE, Barragán-Zúñiga LJ, Arce-Quiñones M, Simental-Mendía M. Effect of ezetimibe on lipoprotein-associated phospholipase A2 mass and activity. A systematic review and meta-analysis of clinical trials. PharmaNutrition. 2026;36:100490. doi:10.1016/j.phanu.2026.100490
BibTeX
@article{SimentalMenda2026,
author = {Simental-Mendía, Luis E. and Barragán-Zúñiga, Laura Jazel and Arce-Quiñones, Mariana and Simental-Mendía, Mario},
title = {Effect of ezetimibe on lipoprotein-associated phospholipase A2 mass and activity. A systematic review and meta-analysis of clinical trials},
journal = {PharmaNutrition},
year = {2026},
volume = {36},
pages = {100490},
doi = {10.1016/j.phanu.2026.100490}
}
EUVIMED